Ian Johnson

Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom.

Biotrace International Plc manufactures and supplies industrial microbiology and life science products. It products include air samplers. The firm supplies products for pharmaceutical manufacturers, hospital laboratories, defense companies and firms that monitor water quality and food safety. The company is headquartered in Bridgend, UK.

Bioquell Ltd. engages in the design, manufacture, and supply of bio-decontamination and containment equipment. It focuses on protecting work from biological contaminants by providing solutions that eliminate problematic bacteria, viruses, fungi, and spores. The company was founded on June 2, 1925 and is headquartered in Andover, the United Kingdom.

Development Bank of Wales Plc provides financial services. It also provides management support, funding, and provides investment services for small and medium sized businesses in Wales. The company was founded in 2001 and is headquartered in Cardiff, the United Kingdom.

Ruskinn Technology Ltd. develops and manufactures specialist microbiology products for the international healthcare market. The company is headquartered in Bridgend, the United Kingdom.

Evans Analytical Group LLC provides micro analytical surface analysis and materials characterization services. The company was founded on May 27, 2005 and is headquartered in Santa Clara, CA.

Lumora Ltd. provides molecular diagnostic products for the clinical and industrial markets. The company was founded by Laurence Carlo Tisi and James A. H. Murray in 2002 and is headquartered in Cambridge, the United Kingdom.

The Institute of Directors provides informative events and professional development courses. The non-profit company is based in Johannesburg, South Africa. Parmesvari Natesan has been the CEO of the South African company since 2010.

Prosonix Ltd. engages in the provision of inhaled respiratory medicines. The company was founded by Andre James Bush and David Hipkiss in 2006 and is headquartered in Oxford, the United Kingdom.

Harwood Private Equity (Harwood Private Equity) is a private equity subsidiary of Harwood Capital LLP founded in 2011 by Christopher Mills. The firm headquartered in London, United Kingdom.

Part of Ecolab, Inc., Bioquell UK Ltd. is a private company that specializes in decontamination and infection control solutions. The company is based in Andover, UK. The British company offers a range of products, including the Bioquell Qube, a modular aseptic workstation for rapid decontamination of samples and process materials. Bioquell's expertise lies in three key technologies: hydrogen peroxide vapor, oxygen peroxide technology, and advanced airborne gas and particulate filtering.

Biofortuna Ltd. provides molecular diagnostic solutions. Its products include SSPGo and ReadyPlex. The firm offers design and development, freeze-drying, manufacturing and dispensing and kitting services. The firm offers its technology on a custom service basis to clients from the clinical, veterinary, food, and research sectors. The company was founded by Mike Bunce, Ben Passey and David Charvill in 2008 and is headquartered in Wirral, the United Kingdom.

Toximet Ltd. develops and manufactures food measurement devices. The firm uses technology includes TOXISep, TOXITrace and TOXIQuant. Its customers include Suresh Exports, Suhana, OLAM, Green Valley and Voicevale. The company was founded by Raymond Douglas Coker in August 2005 and is headquartered in Denbighshire, the United Kingdom.

Founded in 2010, Celsis Group Ltd. is a subsidiary of Charles River Laboratories International, Inc. that manufactures chemical products, electronic measuring and testing equipment. The private company is based in Margate, UK.

Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

Quantum Pharma Holdings Ltd. engages in the manufacture and supply of niche medicines and provision of services to the health care sector. The company was founded on October 17, 2014 and is headquartered in London, the United Kingdom.